Literature DB >> 10393096

39-kDa receptor-associated protein (RAP) facilitates secretion and ligand binding of extracellular region of very-low-density-lipoprotein receptor: implications for a distinct pathway from low-density-lipoprotein receptor.

A Sato1, Y Shimada, J Herz, T Yamamoto, H Jingami.   

Abstract

We have expressed the extracellular regions of the low-density-lipoprotein (LDL) receptor and the very-low-density-lipoprotein (VLDL) receptor, along with the full-length forms of the receptors, in insect cells in a baculovirus system. The extracellular region of the LDL receptor has been secreted successfully into the culture medium, and it retained the capacities of binding 125I-labelled LDL and beta-VLDL. In contrast, the extracellular region of the VLDL receptor remained intracellular and it did not bind 125I-beta-VLDL. This difference in expression behaviour between the homologous regions of the two receptors suggests that the two receptor systems are different in receptor-protein maturation or protein targeting. Next we developed the co-expression system with 39-kDa receptor-associated protein (RAP). This co-expression facilitated the secretion of the extracellular region of the VLDL receptor into the culture medium and the secreted receptor bound 125I-beta-VLDL. The VLDL receptor remaining intracellular that was co-expressed with RAP also showed binding capacity to 125I-beta-VLDL, implying that the existence of RAP prevented receptor-protein aggregation or improved protein-folding status of the truncated VLDL receptor. On the other hand, expression of the extracellular region of the LDL receptor was not facilitated by RAP co-expression. Thus RAP plays an essential role in maintenance of the active conformation and secretion of the extracellular region of the VLDL receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393096      PMCID: PMC1220370     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli.

Authors:  T Simmons; Y M Newhouse; K S Arnold; T L Innerarity; K H Weisgraber
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors.

Authors:  T E Willnow; A Rohlmann; J Horton; H Otani; J R Braun; R E Hammer; J Herz
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.

Authors:  I Mikhailenko; D Krylov; K M Argraves; D D Roberts; G Liau; D K Strickland
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain.

Authors:  D H Kim; H Iijima; K Goto; J Sakai; H Ishii; H J Kim; H Suzuki; H Kondo; S Saeki; T Yamamoto
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

5.  Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.

Authors:  G Bu; S Rennke
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

6.  Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module.

Authors:  D Fass; S Blacklow; P S Kim; J M Berger
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

Review 7.  RAP, a novel type of ER chaperone.

Authors:  G Bu; A L Schwartz
Journal:  Trends Cell Biol       Date:  1998-07       Impact factor: 20.808

8.  The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.

Authors:  K M Argraves; F D Battey; C D MacCalman; K R McCrae; M Gåfvels; K F Kozarsky; D A Chappell; J F Strauss; D K Strickland
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

9.  Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia.

Authors:  U Beisiegel; W J Schneider; J L Goldstein; R G Anderson; M S Brown
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  Visualization of lipoprotein receptors by ligand blotting.

Authors:  T O Daniel; W J Schneider; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

View more
  1 in total

1.  Mapping the binding region on the low density lipoprotein receptor for blood coagulation factor VIII.

Authors:  James H Kurasawa; Svetlana A Shestopal; Elena Karnaukhova; Evi B Struble; Timothy K Lee; Andrey G Sarafanov
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.